CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-31 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +28,225 | 125,043 | ||
| 2026-01-31 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −28,225 | 84,675 | ||
| 2026-01-31 | Howton David T Chief Operating Officer | Option exercise 10b5-1 | +42,275 | 154,254 | ||
| 2026-01-31 | Howton David T Chief Operating Officer | Option exercise · Restricted Stock Units 10b5-1 | −42,275 | 126,825 | ||
| 2026-01-31 | Herzich Paul Chief Technology Officer | Option exercise 10b5-1 | +24,675 | 106,222 | ||
| 2026-01-31 | Herzich Paul Chief Technology Officer | Option exercise · Restricted Stock Units 10b5-1 | −24,675 | 74,025 | ||
| 2026-01-31 | Ganot Ilan Director | Option exercise 10b5-1 | +15,000 | 32,476 | ||
| 2026-01-31 | Ganot Ilan Director | Option exercise · Restricted Stock Units 10b5-1 | −15,000 | 45,000 | ||
| 2026-01-29 | Howton David T Chief Operating Officer | Grant or award · Restricted Stock Units 10b5-1 | +79,341 | 79,341 | ||
| 2026-01-29 | Cumbo Alexander President and CEO | Grant or award · Restricted Stock Units 10b5-1 | +169,401 | 169,401 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Grant or award · Restricted Stock Units 10b5-1 | +58,847 | 58,847 | ||
| 2026-01-29 | Herzich Paul Chief Technology Officer | Grant or award · Restricted Stock Units 10b5-1 | +54,925 | 54,925 | ||
| 2026-01-29 | Tan Kevin CFO & Treasurer | Grant or award · Restricted Stock Units 10b5-1 | +56,647 | 56,647 | ||
| 2026-01-29 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Restricted Stock Units 10b5-1 | +54,925 | 54,925 | ||
| 2026-01-29 | Tan Kevin CFO & Treasurer | Option exercise 10b5-1 | +56,646 | 102,746 | ||
| 2026-01-29 | Tan Kevin CFO & Treasurer | Option exercise · Performance Stock Units 10b5-1 | −56,646 | 0 | ||
| 2026-01-29 | Tan Kevin CFO & Treasurer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +187,000 | 187,000 | ||
| 2026-01-29 | Tan Kevin CFO & Treasurer | Grant or award · Restricted Stock Units 10b5-1 | +93,500 | 93,500 | ||
| 2026-01-29 | Cumbo Alexander President and CEO | Option exercise 10b5-1 | +169,401 | 250,789 | ||
| 2026-01-29 | Cumbo Alexander President and CEO | Option exercise · Performance Stock Units 10b5-1 | −169,401 | 0 |
Page 4 of 12 · 223 trades